Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1969 1
1970 1
1974 1
1977 1
1979 1
1980 2
1982 3
1987 1
1991 4
1992 3
1993 1
1994 1
1995 3
1996 2
1998 4
1999 6
2000 4
2001 5
2002 9
2003 6
2004 8
2005 10
2006 14
2007 11
2008 10
2009 18
2010 19
2011 14
2012 23
2013 23
2014 30
2015 30
2016 37
2017 51
2018 45
2019 38
2020 55
2021 66
2022 48
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

543 results
Results by year
Filters applied: . Clear all
Page 1
Lipoxins in inflammation.
Sachdeva S, Saluja H, Mani A, Phadnaik MB, Mani S. Sachdeva S, et al. Among authors: mani a. Clin Hemorheol Microcirc. 2022;82(3):201-216. doi: 10.3233/CH-211346. Clin Hemorheol Microcirc. 2022. PMID: 35147530
Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial.
Emens LA, Esteva FJ, Beresford M, Saura C, De Laurentiis M, Kim SB, Im SA, Wang Y, Salgado R, Mani A, Shah J, Lambertini C, Liu H, de Haas SL, Patre M, Loi S. Emens LA, et al. Among authors: mani a. Lancet Oncol. 2020 Oct;21(10):1283-1295. doi: 10.1016/S1470-2045(20)30465-4. Lancet Oncol. 2020. PMID: 33002436 Clinical Trial.
Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial.
Turner N, Dent RA, O'Shaughnessy J, Kim SB, Isakoff SJ, Barrios C, Saji S, Bondarenko I, Nowecki Z, Lian Q, Reilly SJ, Hinton H, Wongchenko MJ, Kovic B, Mani A, Oliveira M. Turner N, et al. Among authors: mani a. Breast Cancer Res Treat. 2022 Feb;191(3):565-576. doi: 10.1007/s10549-021-06450-x. Epub 2021 Dec 3. Breast Cancer Res Treat. 2022. PMID: 34860318 Free PMC article. Clinical Trial.
PDE4DIP in health and diseases.
Mani A. Mani A. Cell Signal. 2022 Jun;94:110322. doi: 10.1016/j.cellsig.2022.110322. Epub 2022 Mar 26. Cell Signal. 2022. PMID: 35346821 Review.
Sugar, Fat, and YAP: A Recipe for Vascular Stiffness.
Mani A, Hwa J, Martin KA. Mani A, et al. Circ Res. 2022 Mar 18;130(6):868-870. doi: 10.1161/CIRCRESAHA.122.320880. Epub 2022 Mar 17. Circ Res. 2022. PMID: 35298300 No abstract available.
The role of endogenous bromotyrosine in health and disease.
Sabir M, Tan YY, Aris A, Mani AR. Sabir M, et al. Among authors: mani ar. Free Radic Res. 2019 Oct;53(9-10):1019-1034. doi: 10.1080/10715762.2019.1668560. Epub 2019 Sep 26. Free Radic Res. 2019. PMID: 31530194 Review.
543 results